KPIs & Operating Metrics(New)

Gsk (GSK) Assets Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.67%
Dec 31, 2025 -5.20%
Jun 30, 2025 -5.54%
Mar 31, 2025 -6.70%
Dec 31, 2024 -5.72%
Sep 30, 2024 -5.98%
Jun 30, 2024 -2.18%
Mar 31, 2024 -1.78%
Dec 31, 2023 -0.40%
Sep 30, 2023 0.18%
Jun 30, 2023 -1.07%
Mar 31, 2023 -1.83%
Dec 31, 2022 -1.18%
Sep 30, 2022 -1.57%
Jun 30, 2022 8.55%
Mar 31, 2022 -3.81%
Dec 31, 2021 7.74%
Sep 30, 2021 7.02%
Jun 30, 2021 5.40%
Mar 31, 2021 6.64%
Dec 31, 2020 5.54%
Jun 30, 2020 4.73%
Mar 31, 2020 4.22%
Dec 31, 2019 9.73%
Sep 30, 2019 8.79%
Jun 30, 2019 4.60%
Mar 31, 2019 4.32%
Dec 31, 2018 1.86%
Sep 30, 2018 3.69%
Jun 30, 2018 3.98%
Mar 31, 2018 3.22%
Dec 31, 2017 81.83%
Sep 30, 2017 3.78%
Jun 30, 2017 2.05%
Mar 31, 2017 2.74%
Dec 31, 2016 80.97%
Sep 30, 2016 2.99%
Jun 30, 2016 3.82%
Mar 31, 2016 2.75%
Dec 31, 2015 3.98%
Sep 30, 2015 4.94%
Jun 30, 2015 5.35%
Mar 31, 2015 4.81%
Dec 31, 2014 -1.66%
Sep 30, 2014 -0.19%
Jun 30, 2014 3.26%
Mar 31, 2014 3.15%